日本ヘルスケアにおける人工知能(AI)市場規模、シェア、競争環境、トレンド分析レポート:提供製品別(ソフトウェア、ハードウェア、ソリューション、サービス)、用途別(クリティカルケア、不正検出、投薬ミス削減、ロボット支援手術、初期診断、バーチャル看護アシスタント、事務ワークフロー支援、治験参加者の特定、医療管理およびサポート、その他)、エンドユーザー別(患者、病院およびクリニック、ヘルスケア提供者、契約研究機関(CRO)、製薬およびバイオテクノロジー企業、その他): 2025年から2033年までの機会分析および業界予測
JAPAN ARTIFICIAL INTELLIGENCE AI IN HEALTHCARE MARKET REPORT - TABLE OF CONTENTS
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
- 3.1 Market Highlights
4. VOICE OF CUSTOMER
- 4.1 Product and Market Intelligence
- 4.2 Factors Considered in Purchase Decisions
- 4.2.1. Features
- 4.2.2. Compatibility
- 4.2.3. Durability
- 4.2.4. Efficiency of Solutions
- 4.2.4. After-Sales Support
- 4.2.5. Consideration of Regulations
5. MARKET DYNAMICS
- 5.1. Market Overview
- 5.2. Demand Supply Analysis
- 5.3. Import and Export Analysis
- 5.4. Value Chain Analysis
- 5.5. Porter’s Five Forces Analysis
- 5.6. PESTLE Analysis
- 5.7. Pricing Analysis
- 5.8. Market Dynamics
- 5.9 MARKET DRIVERS
- 5.9.1 Improved diagnosis process
- 5.10 MARKET RESTRAINTS
- 5.10.1 Complexities in adopting AI systems
- 5.11 MARKET OPPORTUNITY
- 5.11.1 Technological advancements in AI for the healthcare industry
- 5.12 PORTER'S FIVE FORCE ANALYSIS
- 5.12.1 Bargaining Power of Buyers/Consumers
- 5.12.2 Bargaining Power of Suppliers
- 5.12.3 Threat of New Entrants
- 5.12.4 Threat of Substitute Products
- 5.12.5 Intensity of Competitive Rivalry
6. MARKET SEGMENTATION (Market Size by Value - USD 2025-2033)
- 6.1 By Offering
- 6.1.1. Software
- 6.1.2. Hardware
- 6.1.3. Solutions
- 6.1.4. Services
- 6.2 By Application
- 6.2.1. Critical Care
- 6.2.2. Fraud Detection
- 6.2.3. Dosage Error Reduction
- 6.2.4. Robot-Assisted Surgery
- 6.2.5. Preliminary Diagnosis
- 6.2.6. Virtual Nursing Assistant
- 6.3.7. Administrative Workflow Assistance
- 6.3.8. Clinical Trial Participant Identifier
- 6.3.9. Medical Administration & Support
- 6.3.10. Other Applications
- 6.3 By End-User
- 6.3.1. Patients
- 6.3.2. Hospitals & Clinics
- 6.3.3. Healthcare Providers
- 6.3.4. Contract Research Organization
- 6.3.5. Pharmaceutical & Biotechnology Companies
- 6.3.6. Others
- 6.4 By Region
- 6.4.1. North [Hokkaido and Tohoku]
- 6.4.2. Central [Kanto and Chubu]
- 6.4.3. South [Kansai, Chugoku, Shikoku, and Kyushu & Okinawa]
7. COMPETITIVE LANDSCAPE
- 7.1. Expansion and Acquisition Analysis
- 7.1.1. Expansion
- 7.1.2. Acquisitions
- 7.2. Partnerships/Collaborations/Agreements/Exhibitions
8 PATENT LANDSCAPE
9 CASE STUDIES
10. COMPANY PROFILES
- 10.1 Ubie
- 10.2 LPixel
- 10.3 Molcure
- 10.4 Atonarp
- 10.5 BIPROGY
- 10.6 Medmain
- 10.7 ThinkCyte
- 10.8 Hacarus
- 10.9 Cyberdyne
- 10.10 A-Traction
- 10.11 IBM Japan
- 10.12. Hitachi, Ltd.
- 10.13 Microsoft Japan
- 10.14 Rakuten Medical
- 10. 15 Cardio Intelligence
- 10.16. AI Medical Service
- 10.17. FRONTEO Healthcare
- 10.18. MedVenture Partners, Inc.
- 10.19. Others
*List Not Exhaustive
11. MARKET OPPORTUNITIES AND FUTURE TRENDS
12. STRATEGIC RECOMMENDATIONS
13. ABOUT US AND DISCLAIMER
無料サンプルを入手する
この無料サンプルには、トレンド分析から推定・予測まで、さまざまなデータが含まれています。
最新レポート
お問い合わせ
-
- JAPAN : 03-6899-2648
-
- EMAIL : sales@reportocean.co.jp